Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 25;33(173):240096.
doi: 10.1183/16000617.0096-2024. Print 2024 Jul.

Bronchiectasis in Asia: a review of current status and challenges

Hayoung Choi  1 , Jin-Fu Xu  2   3 , Sanjay H Chotirmall  4   5 , James D Chalmers  6 , Lucy C Morgan  7 , Raja Dhar  8
Affiliations
Review

Bronchiectasis in Asia: a review of current status and challenges

Hayoung Choi et al. Eur Respir Rev. .

Abstract

Recent bronchiectasis studies from large-scale multinational, multicentre registries have demonstrated that the characteristics of the disease vary according to geographic region. However, most perspectives on bronchiectasis are dominated by data from Western countries. This review intends to provide an Asian perspective on the disease, focusing on the established registries in India, Korea and China. Asian patients with bronchiectasis are less likely to show female predominance and experience exacerbations, are more likely to be younger, have milder disease, and have fewer options for guideline-recommended treatment than those living in other global regions. Furthermore, Asian bronchiectasis patients demonstrate different comorbidities, microbiological profiles and unique endophenotypes, including post-tuberculosis and dry bronchiectasis. Notably, each Asian region reveals further geographic variations and inter-patient differences. Future studies are warranted to better characterise Asian patients with bronchiectasis.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: H. Choi reports grant from the Basic Science Research Program of the Korean Ministry of Education (grant no. 2021R1I1A3052416); and consulting and lecture fees from Boryung Pharmaceutical Co., Ltd. and Kolon Pharma. J-F. Xu reports leadership or fiduciary roles in other boards, societies, committees, or advocacy groups (unpaid) with the Shanghai Medical Association, Chinese Thoracic Society, and Chinese Association of Chest Physicians. S.H. Chotirmall has served on advisory boards for CSL Behring, Pneumagen Ltd and Boehringer Ingelheim, on data monitoring boards for Inovio Pharmaceuticals and Imam Abdulrahman Bin Faisal University, and has received personal fees from AstraZeneca and Chiesi Farmaceutici, all unrelated to this work J.D. Chalmers reports grants or contracts from AstraZeneca, Boehringer Ingelheim, Genentech, Gilead Sciences, GlaxoSmithKline, Grifols, Insmed, LifeArc and Novartis; and consulting fees from AstraZeneca, Chiesi, GlaxoSmithKline, Insmed, Grifols, Novartis, Boehringer Ingelheim, Pfizer, Janssen, Antabio and Zambon. L.C. Morgan reports payment or honoraria for speakers’ bureau from Boehringer Ingelheim, AstraZeneca and Insmed, and educational events from GSK Pharmaceutical and AstraZeneca, all unrelated to this work. In addition, L.C. Morgan reports a leadership or fiduciary role in other boards, societies, committees, or advocacy groups (unpaid) as Chair of the Lung Foundation Australia. R. Dhar reports grants from GSK Pharmaceutical and Glenmark and Thorasis; and lecture fees from Cipla Ltd., Lupin Respira, Glenmark, Abbott, Sanofi and AstraZeneca.

Figures

FIGURE 1
FIGURE 1
Profiles of Asian bronchiectasis. BMI: body mass index; P.: Pseudomonas; TB: tuberculosis.
See this image and copyright information in PMC

Comment in

  • doi: 10.1183/16000617.0124-2024

References

    1. Chalmers JD, Chang AB, Chotirmall SH, et al. . Bronchiectasis. Nat Rev Dis Primers 2018; 4: 45. doi:10.1038/s41572-018-0042-3 - DOI - PubMed
    1. O'Donnell AE. Bronchiectasis – a clinical review. N Engl J Med 2022; 387: 533–545. doi:10.1056/NEJMra2202819 - DOI - PubMed
    1. Aksamit TR, O'Donnell AE, Barker A, et al. . Adult patients with bronchiectasis: a first look at the US bronchiectasis research registry. Chest 2017; 151: 982–992. doi:10.1016/j.chest.2016.10.055 - DOI - PMC - PubMed
    1. Chalmers JD. Bronchiectasis from 2012 to 2022. Clin Chest Med 2022; 43: 1–6. doi:10.1016/j.ccm.2021.12.001 - DOI - PubMed
    1. Chalmers JD, Aliberti S, Polverino E, et al. . The EMBARC European Bronchiectasis Registry: protocol for an international observational study. ERJ Open Res 2016; 2: 00081-2015. doi:10.1183/23120541.00081-2015 - DOI - PMC - PubMed

LinkOut - more resources